OAK BROOK - Bio-Bridge Science Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced Monday that the Japanese Patent Office has issued a patent regarding the use of the papilloma pseudovirus. Bio-Bridge Science has previously been granted patents relating to the technology in the United States and China.
posted: 4/13/2010 12:01 AM
Bio-Bridge gains Japan patent
Order Reprint Print Article
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.
Success - request sent close